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Coordinated actions of the actin cytoskeleton and microtu-
bule (MT) network are essential for several critical cellular 
processes, including formation of the leading edge and focal 
adhesions during cell migration, and of the intercellular bridge 
during cytokinesis (Green et al., 2012; Etienne-Manneville, 
2013). The subset of MTs involved in these processes are 
often more stable than the bulk of MTs and typically accu-
mulate a variety of posttranslational modifications (Wloga 
and Gaertig, 2010; Janke and Bulinski, 2011). Posttransla-
tional modifications of tubulin are read by molecular motors 
and can be used to target them and their cargo to subpopula-
tions of MTs that have been stabilized (Kreitzer et al., 1999; 
Lin et al., 2002; Reed et al., 2006; Dompierre et al., 2007; 
Konishi and Setou, 2009).
Although the majority of posttranslational modifications 
of tubulin are on the exterior of the MT, acetylation on the K40 
residue of α-tubulin occurs in the MT lumen (Nogales et al., 
1999) and could affect the binding of proteins that are trans-
ported along the interior of the MT (Burton, 1984; Garvalov et 
al., 2006; Bouchet-Marquis et al., 2007). Tubulin acetylation 
does not significantly change the ultrastructure of MTs or the 
conformation of tubulin (Howes et al., 2014), but it has been 
recently reported that α-tubulin acetylation weakens lateral in-
terprotofilament interactions that enhance MT flexibility and 
thereby protect MTs from mechanical stress (Portran et al., 
2017; Xu et al., 2017). In mammalian cells, tubulin acetyl-
ation marks MTs found in primary cilia, centrioles, a subset 
of cytoplasmic MT arrays, mitotic spindles, and intercellular 
cytokinetic bridges (Perdiz et al., 2011). Tubulin acetylation is 
important for early polarization events in neurons (Reed et al., 
2006; Hammond et al., 2010), cell adhesion and contact inhi-
bition of proliferation in fibroblasts (Aguilar et al., 2014), and 
touch sensation in Caenorhabditis elegans and mice (Shida et al., 
2010; Kalebic et al., 2013; Kim et al., 2013; Aguilar et al., 2014; 
Morley et al., 2016). Increased tubulin acetylation has been ob-
served in cystic kidney disease (Berbari et al., 2013), whereas 
decreased acetylation is linked to neurodegenerative disor-
ders such as Alzheimer’s, Huntington’s, and Charcot-Marie- 
Tooth (CMT) diseases (Dompierre et al., 2007; Kazantsev and 
Thompson, 2008; d’Ydewalle et al., 2011; Qu et al., 2017). 
Despite its importance, the mechanism that regulates MT 
acetylation remains unknown.
Formins are a widely expressed family of proteins 
whose primary function is to nucleate monomeric globular 
actin (G-actin) to form linear filaments of actin (F-actin; Wal-
lar and Alberts, 2003; Goode and Eck, 2007). In addition to 
their role in actin dynamics, formin functions affect the MT 
cytoskeleton (Goode and Eck, 2007; Bartolini and Gundersen, 
2010; Chesarone et al., 2010). Most formins analyzed bind 
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to MTs (Palazzo et al., 2001; Zhou et al., 2006; Bartolini et 
al., 2008; Young et al., 2008; Cheng et al., 2011; Gaillard et 
al., 2011), and the overexpression of deregulated fragments 
produces coalignment of MTs and actin filaments (Ishizaki et 
al., 2001), promotes MT stabilization (Palazzo et al., 2001), 
and induces tubulin acetylation (Copeland et al., 2004; Young 
et al., 2008; Thurston et al., 2012). Inverted formin 2 (INF2) 
was originally characterized as an atypical formin that, in ad-
dition to polymerizing actin, as other formins do, causes sev-
ering and disassembly of actin filaments in vitro. The latter 
two activities require the diaphanous autoregulatory domain 
(DAD), which in INF2 contains a Wiskott-Aldrich syndrome 
homology region 2 (WH2) motif that binds G-actin (Chhabra 
and Higgs, 2006). A second feature of INF2 is that the in vitro 
binding of G-actin to the WH2/DAD releases INF2 from its 
autoinhibitory state, thereby activating actin polymerization 
(Ramabhadran et al., 2013). INF2 regulates vesicular trans-
port (Andrés-Delgado et al., 2010; Madrid et al., 2010), mito-
chondrial fission (Korobova et al., 2013; Manor et al., 2015), 
prostate cancer cell migration and invasion (Jin et al., 2017), 
focal adhesion elongation and maturation (Skau et al., 2015), 
and podosome formation and size (Panzer et al., 2016). It also 
remodels perinuclear actin in response to mechanical stim-
ulation and increased intracellular calcium levels (Shao et 
al., 2015; Wales et al., 2016). Like other formins (Bartolini 
and Gundersen, 2010), INF2 binds to MTs (Gaillard et al., 
2011; Bartolini et al., 2016) and promotes the formation of 
stabilized MT arrays (Andrés-Delgado et al., 2012; Bartolini 
et al., 2016), and its overexpression induces MT acetylation 
(Thurston et al., 2012). Mutations in the diaphanous inhibi-
tory domain (DID) of INF2 have been found to cause focal 
segmental glomerulosclerosis (FSGS), a degenerative kidney 
disease, with or without associated CMT neuropathy (Brown 
et al., 2010; Boyer et al., 2011).
Given the importance and the specific regulatory proper-
ties of INF2, in this study we have investigated the impact of 
INF2 on tubulin acetylation. We show that INF2 knockdown 
(KD) or knockout (KO) causes a profound and general drop 
in tubulin acetylation in human retinal epithelial 1 (RPE-1) 
cells. Neither drugs that inhibit tubulin deacetylation nor those 
that increase MT stability were able to correct this effect. The 
lack of tubulin acetylation was accompanied by a dramatic 
decrease in the mRNA levels of α-tubulin acetyltransferase (α-
TAT1), which is the enzyme responsible for α-tubulin acetyla-
tion (Shida et al., 2010; Kalebic et al., 2013; Kim et al., 2013; 
Aguilar et al., 2014), and by an increase in the G-/F-actin 
ratio. The exogenous expression of α-TAT1 restored tubulin 
acetylation in INF2-silenced cells. Further work revealed that 
the actin/myocardin–related transcription factor (MRTF)/
serum response factor (SRF) transcriptional circuit, which 
is known to be repressed by increased levels of free G-actin 
(Posern and Treisman, 2006; Olson and Nordheim, 2010), 
controls α-TAT1 transcription, and that INF2 influences tubu-
lin acetylation by regulating this circuit. In addition to RPE-1 
cells, INF2 was important for tubulin acetylation in epithelial 
ECV304 cells, but not in Jurkat T cells, indicating that INF2 
regulates tubulin acetylation in a cell type–specific manner. 
Because MT abnormalities are thought to play a role in FSGS 
and FSGS plus CMT caused by INF2 mutations (Shaye and 
Greenwald, 2015), our demonstration that INF2 is crucial for 
tubulin acetylation in some types of cell may further our un-
derstanding of the molecular basis of these diseases.
Results
Tubulin acetylation is dramatically blocked 
in INF2 KD cells
The axoneme of primary cilia is formed by MTs that are ex-
tensively modified by acetylation of α-tubulin, facilitating the 
monitoring of this posttranslational MT modification. Tubulin 
acetylation is also very prevalent in the intercellular bridge 
formed during cytokinesis and, in interphase cells, in centrioles 
and specific MT arrays. To investigate the effect of INF2 silenc-
ing on MT acetylation, we generated RPE-1 cell clones with 
INF2 expression stably knocked down (INF2 KD cells) with 
specific shRNA (Fig. S1, A and B). Expression of Smo-GFP or 
staining of endogenous Arl13b, two ciliary membrane proteins, 
was used to visualize the cilium. It is of particular note that 
the percentage of cells with acetylated axonemes was greatly 
reduced in INF2 KD cells, whereas that of cells with polyglu-
tamylated axonemes was unaffected (Fig. 1, A and B). The size 
of the cilia and the number of ciliated cells were unaffected by 
INF2 KD (Fig. S1, C and D). The analysis of a cell clone si-
lenced with a different INF2 shRNA gave similar results (Fig. 
S1, E–H). Acetylation, but not polyglutamylation, of the MTs 
of the intercellular bridge formed during cytokinesis was com-
promised in INF2 KD cells (Fig. 1, C and D), as was the acetyl-
ation of centrioles (Fig. 1, E and F). Consistent with a general 
defect in MT acetylation, the cytoplasm of INF2 KD cells in 
interphase lacked detectable acetylated MT arrays (Fig.  1, G 
and H), although the organization of the MT cytoskeleton, as 
revealed by staining for α-tubulin, was normal (Fig. S1 I). The 
effect of INF2 KD on tubulin acetylation in RPE-1 cells was 
confirmed by assessing the levels of acetylated tubulin by im-
munoblot analysis (Fig. 1, I and J).
To investigate whether INF2 is required for tubulin acetyl-
ation in cell lines other than RPE-1 cells, we used CRI SPR/
Cas9 gene editing to prepare INF2 KO cell clones of epithe-
lial ECV304 cells and Jurkat T cells. As control, we observed 
that INF2 KO in RPE-1 cells reproduced the results obtained 
with RPE-1 KD cells (Fig. S2, A–E). Although more than 50 
candidates were examined, we did not obtain ECV304 cell 
clones with complete silenced expression of INF2, suggesting 
that the complete elimination of INF2 expression in this cell 
line might be deleterious. Consistent with the observations in 
RPE-1 cells, ECV304 cells with approximately half the con-
tent of INF2, which is probably the consequence of the KO 
of only one of the alleles, showed reduced tubulin acetylation 
(Fig. S2, F–J). In contrast, tubulin acetylation was unaffected 
in INF2 KO Jurkat T cell clones (Fig. S2, K–O). In conclusion, 
INF2 controls tubulin acetylation in RPE-1 and ECV304 cells 
but not in all cell types.
Absence of tubulin acetylation in INF2 
KD cells is not caused by defects in MT 
stabilization or enhanced deacetylation
Tubulin acetylation accumulates in a subset of MTs that are 
more stable than the bulk of MTs. The accumulation of acetyl-
ated tubulin appears to be a consequence of the long duration 
of those MTs and not the cause of their stabilization (Palazzo 
et al., 2003). Cell treatment with MT-stabilizing drugs, such as 
taxol, promotes tubulin hyperacetylation (Piperno et al., 1987). 
To examine in detail the relationship between INF2 and tubulin 
acetylation, we used the RPE-1 cell line for subsequent exper-
iments. First, we incubated cells in the presence or absence of 
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Figure 1. INF2 KD produces a general block in α-tubulin acetylation in RPE-1 cells. (A and B) Control or INF2 KD cells expressing Smo-GFP (top) or not (bot-
tom) were stained for acetylated tubulin (Ac-tub) and γ-tubulin (γ-tub) in the same fluorescence channel (top) or for polyglutamylated tubulin (pGlu-tub) and 
endogenous Arl13b (bottom). Smo-GFP and Arl13b were used to visualize the ciliary membrane (A). (B) The number of primary cilia positive for pGlu-tub 
or Ac-tub in control and INF2 KD cells was quantified and expressed as the percentage of the total number of primary cilia examined (n = 300–450 per 
experimental point). (C and D) Control and INF2 KD cells were stained for Ac-tub and pGlu-tub. Only cells in cytokinesis are shown (C). (D) The number of 
control and INF2 KD cells with the intercellular bridge stained for acetylated tubulin was quantified and expressed as the percentage of the total numbers 
of bridges examined (n = 300–400 cells per experimental point). (E and F) To visualize the centrioles, control or INF2 KD cells were treated with 10 µM 
nocodazole for 2 h at room temperature, followed by an additional 30 min at 4°C. Cells were fixed with cold methanol for 6 min. Cells were finally 
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taxol for 3 h and stained them for acetylated tubulin to deter-
mine whether the lack of tubulin acetylation in INF2 KD cells 
is caused by defective MT stabilization. Cells were scored as 
MT hyperacetylated cells when the level of MT acetylation, as 
determined by measuring the signal intensity of the labeling, 
was at least three times that of the mean level of control cells. 
Using this criterion, fewer than 5% of control cells showed 
hyperacetylated MTs. In contrast to the high percentage of 
MT-hyperacetylated cells observed in the case of control cells 
treated with taxol, no effect in tubulin acetylation was detected 
in taxol-treated INF2 KD cells (Fig. 2, A and B). This result 
was confirmed by immunoblotting (Fig. 2, C and D). Tubacin 
is known to increase the levels of tubulin acetylation by inhib-
iting histone deacetylase 6 (HDAC6), which deacetylates MTs 
(Haggarty et al., 2003). To investigate whether the deficiency 
in tubulin acetylation is caused by enhanced deacetylation by 
HDAC6, we treated control and INF2 KD RPE-1 cells with 
tubacin or with its inactive analogue, niltubacin. As expected, 
the percentage of cells with hyperacetylated MTs increased in 
control cells treated with tubacin, whereas no effect was ob-
served in INF2 KD cells (Fig. 2, E and F). The lack of effect of 
tubacin on tubulin acetylation in INF2 KD cells was confirmed 
by immunoblotting (Fig. 2, G and H). Together, the results in 
Fig. 2 suggest that the lack of tubulin acetylation in INF2 KD 
RPE-1 cells is not a consequence of defective MT stabilization 
or enhanced tubulin deacetylation.
INF2 KD cells are depleted of 
α-TAT1 mRNA
A possible explanation of the deficiency of tubulin acetylation 
is that the expression of α-TAT1 is reduced in INF2 KD RPE-1 
cells. Because we did not find any reliable source of antibodies 
to detect endogenous α-TAT1, we measured the expression of 
α-TAT1 mRNA by quantitative PCR. It is of note that, consis-
tent with the acetylation defects observed in INF2 KD cells, we 
found α-TAT1 mRNA levels to be greatly reduced in INF2 KD 
cells compared with control cells (Fig. 3 A). To confirm that the 
lack of α-TAT1 is responsible for the lack of acetylation in INF2 
KD cells, we expressed α-TAT1-GFP to restore tubulin acetyl-
ation in these cells. We observed that expression of α-TAT1-
GFP, but not of its α-TAT1 D157N-GFP mutant, which has only 
residual catalytic activity (Shida et al., 2010), produced tubulin 
hyperacetylation in all the transfected cells (Fig. 3 B). This re-
sult was confirmed by assessing the levels of acetylated tubulin 
by immunoblot analysis (Fig. 3, C and D). The results in Fig. 3 
indicate that the defect in tubulin acetylation observed in INF2 
KD cells was caused by the lack of α-TAT1 expression.
Tubulin acetylation is restored in INF2 KD 
cells by expression of catalytically active 
INF2 fragments
Most formins consist of a carboxyl-terminal domain, known 
as the DAD, which is separated by formin homology (FH) 
domains 1–2 from the DID, which is at the amino terminus. 
The FH1 domain recruits profilin, which binds and supplies 
G-actin to the FH2 domain for actin polymerization (Wallar and 
Alberts, 2003; Goode and Eck, 2007). INF2 is expressed as two 
isoforms, INF2-1 and INF2-2, generated by alternative splicing 
of the exons encoding their carboxyl-terminal end (Fig. 4 A). 
INF2-1, which has an 18-aa carboxyl-terminal sequence con-
taining a motif for farnesylation, localizes to the ER, whereas 
INF2-2, which instead has a 9-aa sequence containing basic 
residues, is cytosolic (Madrid et al., 2010; Ramabhadran et al., 
2011). The I643 residue, which is present in the FH2 domain of 
human INF2, is critical for actin polymerization in vivo (Ram-
abhadran et al., 2012). This residue is equivalent to the I1431 
of yeast formin Bni1p and the I704 of mDia2, which are criti-
cal for actin polymerization by these formins (Xu et al., 2004; 
Harris et al., 2006). However, K792 in the FH2 of human INF2, 
which is equivalent to a K residue critical for actin polymeriza-
tion by Bni1p (K1601) and mDia2 (K853; Xu et al., 2004; Bar-
tolini et al., 2008), is not essential for actin polymerization by 
INF2 (Ramabhadran et al., 2012). On the other hand, mutation 
of three critical leucine residues (L1010, L1011 and L1020) in 
the DAD of mouse INF2, equivalent to L976, L977, and L986 
in human INF2, abrogates the in vitro depolymerization activity 
of INF2 (Chhabra and Higgs, 2006; Chhabra et al., 2009).
We expressed intact human INF2 (INF2-1 and INF2-2) 
or INF2 proteins with I643 (INF2-1 IA and INF2-2 IA), K792 
(INF2-1 KA), or L976, 977, 986 (INF2-1 3LA) substituted by 
Ala (Fig. S3 A) and assayed their ability to induce tubulin hy-
peracetylation in control RPE-1 cells. Whereas the KA and 3LA 
mutants were as active as intact INF2, the IA mutants showed 
a reduced effect (Fig. 4, B and C; and Fig. S3 B). All the INF2 
proteins distributed throughout the cell (Figs. 4 B and S3 B), ex-
cept for the INF2-1 IA mutant, which accumulated in collapsed 
membranous structures that correspond to a modified ER, as in-
dicated by its colocalization with mCherry-ER-3, an ER marker 
(Fig. S3 C). The reduced effect of the IA mutation on tubulin 
hyperacetylation was confirmed by expression of an INF2 IA 
mutant with the alternative carboxyl-terminal sequence deleted 
(INF2 IA ΔAlt; Fig. 4, B and C; and Fig. S3 A).
We also expressed intact INF2 or different INF2 fragments 
to analyze their capacity to restore tubulin acetylation in INF2 KD 
cells (Fig. 4, D and E; and Fig. S3 D). Intact INF2-2 and the frag-
ment consisting of the FH1-FH2 domains induced tubulin acetyl-
ation and so did the FH2 domain, although to a lesser extent. The 
activity of INF2 and its FH2 fragment promoting tubulin acetyla-
tion was abolished by the mutation of the I643 residue (Fig. 4, D 
and E), which also blocks its actin polymerization activity (Ram-
abhadran et al., 2012). It is of note that INF2-2 IA induced a sig-
nificant increase in the percentage of cells with hyperacetylated 
tubulin in control cells (Fig. 4, B and C), but had no effect in INF2 
KD cells (Figs. 4 E and S3 E). This finding indicates that INF2 
overexpression regulates tubulin acetylation in control cells by 
mechanisms that are dependent on and independent of its actin 
stained separately for Ac-tub and γ-tub (E). (F) The number of centrioles positive for Ac-tub in control and INF2 KD cells was quantified and expressed as 
the percentage of the total number of centrioles examined (n = 300–400 cells per experimental point). (G and H) Control and INF2 KD cells were stained 
for Ac-tub. Only cells in interphase are shown (G). (H) The number of control and INF2 KD cells with acetylated MT arrays was quantified and expressed 
as the percentage of the total number of cells examined (n = 300–350 cells per experimental point). In A, C, E, and G, nuclei were visualized with TO-
PRO. Enlargements of the boxed regions are shown. (I and J) Total extracts from control or INF2 KD cells were subjected to immunoblot analysis for Ac-tub, 
pGlu-tub, total α-tubulin (α-tub), and GAP DH (I). (J) The histogram shows the levels of Ac-tub and pGlu-tub in INF2 KD cells relative to those in control cells. 
Bars: (panoramic views) 10 µm; (enlargements) 2 µm. Data in B, D, F, H, and J represent the mean and SEM of three independent experiments; ns, not 
significant; ***, P < 0.001.
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polymerization activity, the independent mechanism probably 
being mediated by MT stabilization. However, in INF2 KD cells, 
only an actin polymerization activity–dependent mechanism op-
erates. The stable expression of either INF2-1 or INF2-2 in INF2 
KO cells restored tubulin acetylation, indicating that both iso-
forms probably help regulate the expression of the α-TAT1 gene 
(Fig. S3, F–H). The results illustrated in Fig. 4 highlight the im-
portance of the FH2 domain of INF2 and its actin polymerization 
activity for promoting tubulin acetylation in RPE-1 cells.
DIA1 KD does not inhibit tubulin 
acetylation or alter the G-/F-actin  
ratio, unlike INF2 KD
To ascertain whether all the formins are equally important for 
MT acetylation in RPE-1 cells, we knocked down the expres-
sion of DIA1 (DIA1 KD cells), which is the human orthologue 
of mouse Dia1 (mDia1; Li and Higgs, 2003), with specific 
shRNA (Fig. 5, A and B). We found that the percentage of cells 
with acetylated MT arrays and the levels of α-TAT1 mRNA 
were unaffected in DIA1 KD cells (Fig. 5, C–E). It is of note 
that DIA1 KD had no significant effect on the G-/F-actin ratio, 
whereas INF2 KD greatly increased it (Fig. 5 F). In conclusion, 
INF2 appears to have a more prominent role than DIA1 in actin 
polymerization and tubulin acetylation in RPE-1 cells.
Despite the lack of effect of DIA1 KD on tubulin acetyl-
ation, the overexpression of mDia1-GFP, constitutive active 
mDia1 ΔN3-GFP mutant, or the isolated FH2 domain of mDia1 
(Fig. S4 A) promoted tubulin acetylation in INF2 KD cells 
(Fig. 5, G and H). The same effect was obtained by overexpres-
sion of the formin FMNL1 or its isolated FH2 domain (Fig. 5 H 
and Fig. S3, I and J). The actin polymerization activity of mDia1 
is abolished by the substitution of three critical lysine residues 
(K989, K994, and K999) by alanine (mDia FH2 KA3; Ishizaki 
et al., 2001). We expressed the FH2 fragment of mDia1 with the 
KA3 mutation and found that, unlike the intact fragment, it was 
unable to restore tubulin acetylation in INF2 KD cells (Fig. 5, G 
and H). These results, together with those in Fig. 4, indicate that 
the overexpression of FH2-containing fragments corrects the 
tubulin acetylation defect of INF2 KD RPE-1 cells, and does 
so only when their actin polymerization activity is preserved.
Figure 2. Absence of tubulin acetylation in INF2 KD cells is not caused by defects in MT stabilization or enhanced deacetylation. (A–D) Control and INF2 
KD RPE-1 cells were left untreated or were treated with 2.5 µM taxol for 2 h and stained for Ac-tub (A). (B) The number of cells with hyperacetylated MTs 
was determined and expressed as the percentage of the total number of cells examined (n = 420–450 cells per experimental point). (C) Cell extracts were 
subjected to immunoblot analysis for Ac-tub and total α-tub. (D) The histogram shows the levels of Ac-tub relative to those in untreated control cells. (E–H) 
Control and INF2 KD cells were treated with 10 µM of either tubacin or niltubacin for 8 h and stained for Ac-tub (E). (F) The number of cells with hyper-
acetylated MT arrays was determined and expressed as the percentage of the total number of cells examined (n = 350–450 cells per experimental point). 
(G) Cell extracts were subjected to immunoblot analysis for Ac-tub and GAP DH. (H) The histogram shows the levels of Ac-tub in INF2 KD cells relative to 
those in untreated control cells. Nuclei were visualized with TO-PRO in A and E. Bars, 10 µm. Data in B, D, F, and H represent the mean and SEM of three 
independent experiments; ns, not significant; ***, P < 0.001.
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Activation of the actin-MRTF-SRF 
transcriptional circuit restores α-TAT1 
mRNA levels and tubulin acetylation in 
INF2 KD cells
SRF is a highly conserved and widely expressed transcription 
factor in mammals (Prywes and Roeder, 1987; Treisman, 1987). 
MRTF coactivators, which regulate SRF activity by forming a 
complex with SRF, are regulated by the levels of cytoplasmic 
and nuclear G-actin (Miralles et al., 2003; Baarlink et al., 2013). 
The requirement for actin polymerization activity to restore MT 
acetylation in INF2 KD cells (Fig. 4, D and E) is consistent with 
the possibility that the actin-MRTF-SRF circuit regulates MT 
acetylation. The transcriptional activity of MRTF-SRF com-
plex was assayed with a luciferase reporter plasmid (5xCArG) 
containing five canonical MRTF-SRF–responsive elements up-
stream from a minimal promoter. When we compared control 
and INF2 KD RPE-1 cells, we found that the transcriptional 
activity of the MRTF-SRF complex is reduced in INF2 KD cells 
(Fig. 6 A). To confirm the reduction in MRTF-SRF transcrip-
tional activity, we evaluated the mRNA levels of several known 
MRTF-SRF transcriptional targets involved in focal adhesions, 
such as the genes encoding the extracellular matrix connective 
tissue growth factor and the cytoskeletal proteins α-actinin 1, 
filamin A, talin 1, tropomyosin 1, and vinculin. We found a sig-
nificant reduction in the levels of the mentioned transcripts to 
an extent that is consistent with the drop in MRTF-SRF activity 
observed in INF2 KD cells (Fig. 6 B). Compared with α-TAT1 
(Fig. 3 A), the effect was more moderate, suggesting that the 
transcription of these genes at steady-state is less dependent 
on the MRTF-SRF complex.
The amino terminus of MRTFs contains a RPEL domain 
that binds five G-actin molecules, resulting in the sequestration 
of the MRTF molecules in the cytosol (Guettler et al., 2008). 
When levels of cytosolic G-actin are low, MRTF is imported into 
Figure 3. INF2 KD cells are depleted in α-TAT1 mRNA. (A) The histogram represents the levels of α-TAT1 mRNA in INF2 KD cells relative to those in control 
RPE-1 cells. (B) Control and INF2 KD cells were transiently transfected with α-TAT1-GFP (top) or α-TAT1 157N-GFP (bottom) and stained for Ac-tub and γ-tub 
in the same fluorescence channel. Nuclei were visualized with TO-PRO. Bars, 10 µm. (C and D) Total extracts from control or INF2 KD cells transiently 
expressing GFP, α-TAT1-GFP, or α-TAT1 157N-GFP were subjected to immunoblot analysis with antibodies to GFP and for Ac-tub and total α-tub. The same 
blot was cut in strips and processed to detect GFP alone, α-TAT1-GFP and α-TAT1 157N-GFP, or Ac-tub (C). (D) The histogram shows the percentage of Ac-
tub in cells expressing α-TAT1-GFP and α-TAT1 157N-GFP relative to that in control cells transfected with GFP alone. Data in A and D represent the mean 
and SEM of three independent experiments; ***, P < 0.001.
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Figure 4. Expression of an intact FH2 domain restores tubulin acetylation in INF2 KD cells. (A) Schematic of the domain organization of INF2. The 
position of the amino acids mutated in the different constructs used and the carboxyl-terminal amino acid sequence of INF2-1 and INF2-2 as well as the 
function of the different domains are indicated. D/W, DAD/WH2 domain. (B and C) Control RPE-1 cells transiently expressing the indicated INF2 proteins 
were stained for Ac-tub and exogenous INF2 (B). (C) The histogram shows the percentage of cells transfected with the indicated constructs showing MT 
hyperacetylation. Fewer than 5% of the control cells showed hyperacetylated MTs. (D and E) INF2 KD RPE-1 cells were left untransfected or were tran-
siently transfected with the indicated INF2 constructs. Cells were stained for Ac-tub and the exogenous INF2 fragments (D). (E) The histogram illustrates 
the percentage of INF2 KD cells transfected with the indicated constructs showing MT acetylation. Nuclei were visualized with TO-PRO in B and D.   
Bars, 10 µm. Data in C and E represent the mean and SEM of three independent experiments (n = 300–400 cells per experimental point); ns, not significant; 
**, P < 0.01; ***, P < 0.001.
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the nucleus and associates with SRF to direct SRF-dependent 
gene transcription. Depletion of G-actin by either stimulation of 
F-actin formation or sequestration of G-actin liberates MRTFs 
from G-actin and allows the nuclear import of MRTF (Posern 
and Treisman, 2006; Olson and Nordheim, 2010). Cytochalasin 
D treatment not only disrupts the MRTF/G-actin complex, lib-
erating MRTF (Olson and Nordheim, 2010), but also induces 
primary cilium formation by a mechanism that is yet to be fully 
characterized (Kim et al., 2010). Cytochalasin D increased 
the percentage of cells with acetylated axoneme and induced 
axoneme hyperacetylation in control cells (Fig. S4, A–C); in 
INF2 KD cells, it restored MRTF-SRF-dependent transcription 
(Fig. 6 A) and axoneme acetylation (Fig. 6, C and D) and in-
creased the total levels of acetylated tubulin (Fig. 6, E and F) 
and α-TAT1 mRNA (Fig. 6 G).
Two related MRTFs, MRTF-A and MRTF-B, have 
been identified in mammalian species (Olson and Nordheim, 
2010). To investigate the involvement of MRTF directly, we 
analyzed the levels of MRTF-A in the nucleus and found that 
they were significantly higher in control cells than in INF2 KD 
cells (Fig. 7, A and B). As control, we observed that the total 
levels of MRTF-A and SRF were similar in control and INF2 
KD RPE-1 cells (Fig. S4 D). It is of particular note that treat-
ment with cytochalasin D altered the distribution of MRTF-A 
Figure 5. INF2 KD but not DIA1 KD alters the G-/F-actin ratio. (A and B) Extracts from control or RPE-1 cells stably expressing shRNA targeted to DIA1 
(DIA1 KD) were immunoblotted for DIA1, Ac-tub, and GAP DH (A). (B) The histogram represents the levels of DIA1 in DIA1 KD cells relative to control cells. 
(C and D) Control or DIA1 KD cells were stained for Ac-tub (C). (D) The number of control and DIA1 KD cells with acetylated MT arrays was quantified 
and as the percentage of the total number of cells examined (n = 350–450 cells per experimental point). (E) The histogram represents the levels of α-TAT1 
mRNA in DIA1 KD cells relative to control cells. (F) The G-/F-actin ratio was determined in control cells, INF2 KD cells, and DIA1 KD cells. (G) INF2 KD 
cells transiently expressing tagged forms of full-length mDia1, the mDia1 ΔN3 mutant, and the intact or KA3 mutant of the FH2 domain of mDia1 were 
stained for Ac-tub and the exogenous proteins. (H) The histogram shows the percentage of cells with acetylated MT arrays in INF2 KD cells expressing the 
mDia1 constructs indicated in (G), full-length FMNL1, or the FMNL1 FH2 domain (n = 300–400 cells per experimental point). Nuclei were visualized with 
TO-PRO in C and G. Bars, 10 µm. Data in B, D, and H represent the mean and SEM of three independent experiments, and those in E and F represent five 
and seven independent experiments, respectively; ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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in INF2 KD cells, making it mostly nuclear as in the control 
cells, with a concomitant increase in the percentage of INF2 
KD cells with acetylated tubulin (Fig. 7, A and B). To further 
demonstrate a role of MRTF in regulating tubulin acetylation, 
we overexpressed the MRTF-A ΔN100 mutant, which lacks 
the amino-terminal 100 aa of MRTF-A containing the RPEL 
domain that binds G-actin and consequently displays consti-
tutive activity (Muehlich et al., 2008). Confirming the role of 
MRTF, we found that MRTF-A ΔN100 expression restored 
tubulin acetylation in INF2 KD cells (Fig. 7, C and D). Consis-
tent with our hypothesis that MRTF-SRF controls α-TAT1 gene 
expression, MRTF-A ΔN100 overexpression activated MRTF-
SRF–mediated gene transcription (Fig.  7  E) and increased 
α-TAT1 mRNA levels in INF2 KD cells (Fig. 7 F). To further 
demonstrate the involvement of MRTF in α-TAT1 expression, 
we used the pan-formin inhibitor SMI FH2 (Rizvi et al., 2009). 
The treatment of control RPE-1 cells with SIM FH2 produced 
the exclusion of endogenous MRTF-A from the nucleus and a 
dramatic reduction in the percentage of cells with acetylated 
MT arrays (Fig. S4, E and F). It is of note that, consistent with 
our results showing the crucial role of MRTF in promoting 
tubulin acetylation, this effect was partially overcome by the 
expression of MRTF-A ΔN100 (Fig. S4, E and F). In conclu-
sion, the actin-MRTF-SRF circuit is dysfunctional in INF2 KD 
RPE-1 cells, and the activation of this circuit corrects the defect 
in tubulin acetylation.
The MRTF-SRF complex directly controls 
transcription of the α-TAT1 gene
Homodimeric SRF recognizes 10-bp DNA elements called 
CArG boxes (Posern and Treisman, 2006). These are classi-
fied into two broad categories, consensus CArG boxes, which 
fit the sequence CC(A/T)6GG (Leung and Miyamoto, 1989); 
and CArG-like boxes, which include elements that do not de-
viate more than 1 bp from the consensus sequences (Sun et al., 
2006). We inspected the human form of α-TAT1 gene for puta-
tive CArG and CArG-like elements in the promoter region and 
the first intron. We found one consensus CArG box (CArG1), 
which was perfectly palindromic, and two CArG-like boxes 
(CArG2 and CArG3) in the promoter region and one CArG-like 
box in the first intron (CArG4; Fig. 8 A). To investigate whether 
the MRTF-SRF complex mediates transcription of the α-TAT1 
gene directly, we cloned three DNA fragments encompassing 
the indicated elements (Prom1, Prom2, and Int1; Fig. 8 A) up-
stream of a minimal promoter followed by the luciferase gene 
reporter (Fig. 8 B). The constructs were transfected in control 
and INF2 KD RPE-1 cells, and their luciferase activity was as-
sayed. In control cells, we observed a marked increase in lucif-
erase activity in all cases in response to incubation with 20% 
FBS compared with the cells transfected with the plasmid con-
taining the minimal promoter alone. In contrast, the effect was 
reduced in INF2 KD cells (Fig. 8 B), as had been previously 
observed for the 5xCArG construct (Fig. 6 A). To confirm that 
Figure 6. The activity of the MRTF-SRF transcriptional complex is defective in INF2 KD RPE-1 cells. (A) Control or INF2 KD RPE-1 cells were transfected 
with plasmids containing the luciferase reporter gene with a minimal promoter (minP) or five canonical CArG boxes followed by the minimal promoter 
(5xCArG). The activity of the MRTF-SRF complex was measured in control cells, INF2 KD cells, and cytochalasin D–treated INF2 KD cells. The values are 
expressed relative to those obtained in control cells transfected with minP. (B) The histogram illustrates the mRNA levels of α-actinin 1 (ACTN1), connective 
tissue growth factor (CTGF), filamin A (FLNA), talin 1 (TLN1), tropomyosin 1 (TPM1), and vinculin (VCL) in INF2 KD cells relative to that in control RPE-1 
cells. The dashed line indicates the values in control cells. (C and D) INF2 KD cells were treated with 0.5 µM cytochalasin D or not for 48 h and stained 
for Ac-tub and pGlu-tub. Note that cytochalasin D treatment promotes the formation of primary cilia. Nuclei were visualized with DAPI. Enlargements of 
the boxed regions are shown. Bars: (panoramic views) 10 µm; (enlargements) 2 µm (C). (D) The histogram represents the percentage of axonemes, as 
visualized by pGlu-tub staining, that were acetylated (n = 365–383 cells per experimental point). (E and F) Total extracts from INF2 KD cells treated or not 
with cytochalasin D were immunoblotted for Ac-tub or GAP DH (E). (F) The histogram shows the levels of Ac-tub in cytochalasin D–treated INF2 KD cells 
relative to those in untreated cells. (G) The level of α-TAT1 mRNA in INF2 KD cells treated with cytochalasin D was quantified and expressed relative to that 
in untreated cells. Data in A and G represent the mean and SEM of six and four independent experiments, respectively; those in B, D, and F represent the 
mean and SEM of five independent experiments; **, P < 0.01; ***, P < 0.001.
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these elements respond to MRTF-SRF activation, we cloned the 
four α-TAT1 gene CArG elements in tandem (CArGs1–4 con-
struct) and measured the luciferase activity in cells expressing 
the active MRTF-A ΔN100 mutant (Figs. 8 C and S4 G). The 
activity of CArGs1-4 was similar to that of the 5xCArG con-
struct, whereas mutation in the central residues of each of the 
α-TAT1 gene CArGs (CArGs1–4m construct) greatly reduced 
its activity. The results presented in Fig.  8 indicate that the 
α-TAT1 gene contains CArG elements that respond to activation 
of the MRTF-SRF transcriptional complex.
Discussion
Lysine acetylation of α-tubulin was first reported more than 30 
years ago (L’Hernault and Rosenbaum, 1985), with K40 being 
identified as the acetylation site (LeDizet and Piperno, 1987). 
K40 acetylation is the most extensively characterized of the 
known tubulin posttranslational modifications (Perdiz et al., 
2011). The function of formins affects the actin and MT cy-
toskeletons (Goode and Eck, 2007; Bartolini and Gundersen, 
2010; Chesarone et al., 2010). Despite the interest aroused, the 
Figure 7. Expression of active MRTF-A restores tubulin acetylation and α-TAT mRNA levels in INF2 KD RPE-1 cells. (A and B) Control and INF2 KD RPE-1 
cells were treated with 0.5 µM cytochalasin D or not for 48 h. Cells were then stained for Ac-tub and endogenous MRTF-A (A). (B) The percentage of 
nuclear MRTF-A and that of cells with acetylated MT arrays were quantified (n = 300–450 cells per experimental point). (C–F) INF2 KD cells expressing 
the active MRTF-A ΔN100 mutant or not were stained for MRTF-A and Ac-tub (C). (D) The percentage of transfected cells with acetylated MT arrays was 
quantified and compared with that of untransfected cells. (E) The activity of the MRTF-SRF complex was measured in INF2 KD cells expressing MRTF-A 
ΔN100 and expressed relative to that in untransfected INF2 KD cells. (F) The level of α-TAT1 mRNA was quantified in MRTF-A ΔN100-transfected INF2 
KD cells and expressed relative to those in untransfected cells. Nuclei were visualized with TO-PRO in A and C. Bars, 10 µm. Data in B, D, and E rep-
resent the mean and SEM of four independent experiments; those in F represent the mean and SEM of three independent experiments; *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.
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mechanism by which formins regulate tubulin acetylation has 
remained puzzling. In this study, we have investigated how the 
formin INF2 controls MT acetylation. We observed that INF2 
KD in RPE-1 cells produced a global defect in MT acetyla-
tion and an increase in the G-/F-actin ratio. The defect in tu-
bulin acetylation was not caused by decreased MT stability or 
increased tubulin deacetylation. It is explained by the almost 
complete absence of α-TAT1 mRNA, which encodes the major 
tubulin acetyltransferase (Shida et al., 2010; Kalebic et al., 
2013). Tubulin acetylation was restored by exogenous expres-
sion of α-TAT1 and treatments that induce activation of MRTF-
SRF–dependent transcription, which is controlled by the levels 
of free monomeric G-actin. Several MRTF-SRF–responsive 
elements were identified as being responsible for the transcrip-
tion of the α-TAT1 gene. In conclusion, the actin-MRTF-SRF 
transcriptional circuit regulates α-TAT1 gene expression, and 
INF2 affects MT acetylation in RPE-1 cells by regulating the 
transcription of the α-TAT1 gene through this circuit.
Overexpression of deregulated FH1FH2-containing frag-
ments from 13 mammalian formins induces to a greater or lesser 
extent tubulin acetylation and activation of MRTF-SRF–depen-
dent transcription (Tominaga et al., 2000; Copeland and Treis-
man, 2002; Copeland et al., 2004; Young et al., 2008; Thurston 
et al., 2012). No absolute correlation was found between the 
tubulin acetylation and MRTF-SRF activation, which, in some 
cases, had a high level for one but a low level for the other. In 
addition, in the case of the formin INF1, the expression of its 
MT binding carboxyl-terminal domain induces tubulin acetyla-
tion but does not modify the activity of the MRTF-SRF complex 
(Young et al., 2008; Thurston et al., 2012). We have observed 
that the overexpression of the actin polymerization-deficient 
INF2 IA caused tubulin hyperacetylation in a population of 
control cells. This effect was probably caused by an increase 
in MT stability (Andrés-Delgado et al., 2012; Bartolini et al., 
2016), because MT stabilization by formins is independent of 
actin polymerization (Bartolini et al., 2008). The effect of over-
expressing intact INF2 was greater because, in addition, it can 
polymerize actin and activate transcription by the MRTF-SRF 
complex. Consistent with these observations, we noted that the 
overexpression of intact INF2-2 or the INF2 FH2 fragment pro-
duced an increase in tubulin acetylation in INF2 KD cells. How-
ever, INF2-2 IA or the INF2 FH2 IA mutant prompted no such 
increase because INF2 KD is depleted in α-TAT1. Based on our 
results and those earlier studies, we propose that formins affect 
tubulin acetylation by both stabilizing MTs and activating the 
transcription of the α-TAT1 gene, although, depending on the 
Figure 8. The α-TAT1 gene contains functional CArG 
boxes. (A) Schematic representation of the α-TAT1 
gene with an indication of the putative CArG boxes 
(CArG elements 1–4) present in the region examined 
and the fragments (Prom1, Prom2, and Int1) used 
in our analysis. (B) The indicated constructs were 
transfected in control and INF2 KD RPE-1 cells. The 
luciferase activity was measured and was expressed 
relative to that of cells transfected with minP. (C) The 
four CArG boxes present in the constructs Prom1, 
Prom2, and Int1 were placed in tandem upstream 
from a minimal promoter (α-TAT1 CArGs1–4). A simi-
lar construct was made in which the four central nucle-
otides of each box were mutated in such a way that 
all of them were C or G (α-TAT1 CArGs1–4m). Con-
trol cells were transfected with the indicated constructs 
in the presence or absence of the MRTF-A ΔN100 
construct, and the luciferase activity of the cells was 
assayed. The histogram represents the luciferase ac-
tivity obtained in each case relative to that of cells 
transfected with minP. Data in B and C represent the 
mean and SEM of seven and four independent exper-
iments, respectively; ns, not significant; *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.
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specific formin, one of the mechanisms dominates the other. For 
instance, in the case of endogenous INF2, the effect on α-TAT1 
gene transcription appears to be more important than that on MT 
stabilization, although the latter can also contribute. In INF2, as 
in most formins, these two activities require the presence of the 
FH2 domain, whereas in the formin INF1 they are segregated 
into different domains: the amino-terminal half containing 
the FH1 and FH2 domains moderately activates MRTF-SRF– 
dependent transcription and does not stabilize MTs, whereas its 
large carboxyl-terminal half, which contains the tubulin-binding 
region, is a potent MT stabilizer but does not activate the 
MRTF-SRF complex (Young et al., 2008). The case of formin 
Fmn1, which has a bipartite amino-terminal MT binding region 
segregated from its FH1 and FH2 domains (Zhou et al., 2006), 
could be similar to that of INF1.
INF2 mutations account for 10–15% of the cases of auto-
somal-dominant FSGS (Brown et al., 2010; Barua et al., 2013) 
and ∼75% of those of FSGS combined with CMT (Boyer et al., 
2011). It is of particular note that whereas most discussions of 
defects underlying kidney disease and neuropathy for patients 
with INF2-related syndromes focus on the role of INF2 in mod-
ulating the actin cytoskeleton, studies conducted in C. elegans 
with disease-associated INF2 mutations point to an effect of 
mutant INF2 on both MTs and actin (Shaye and Greenwald, 
2015). The MRTF-SRF complex is known to regulate the tran-
scription of a large number of genes that encode regulators of 
the cytoskeleton, transcription, and cell growth and metabolism. 
Among the cytoskeleton genes regulated by MRTF-SRF are 
genes involved in actin dynamics, cell adhesion, extracellular 
matrix synthesis and processing, and cell motility and genes in-
volved in MT-based cytoskeletal dynamics (Esnault et al., 2014; 
Gualdrini et al., 2016). Consequently, changes in INF2 activity 
in RPE-1 cells can control actin homeostasis and modulate the 
expression of α-TAT1 and a large number of other genes related 
to cytoarchitecture that are regulated by the actin-MRTF-SRF 
transcriptional circuit. Therefore, INF2 can control not only 
tubulin acetylation, but also more extensive cytoskeleton re-
modeling, as has been observed in the cases of dorsal stress 
fibers and fibrillar focal adhesion formation (Skau et al., 2015), 
and in perinuclear actin remodeling in response to mechanical 
force (Shao et al., 2015).
As is the case with RPE-1 cells, INF2 appears to be import-
ant for tubulin acetylation in ECV304 cells. However, tubulin 
acetylation in Jurkat T cells is controlled by another mechanism. 
Because the regulation of transcription by the MRTF-SRF by free 
G-actin is probably universal in mammalian cells, it is possible 
that the CArG elements in the α-TAT1 gene are not functional in 
all types of cells or that G-actin homeostasis is regulated in a dif-
ferent manner, by INF2 in certain cell types and, for instance, by 
another formin more prominent than INF2 in actin polymeriza-
tion in others. In conclusion, our findings shed new light on the 
coordination of the actin cytoskeleton and MTs. This may help 
explain the molecular basis of INF2-related disease (Brown et 
al., 2010; Boyer et al., 2011) and the alterations in tubulin acetyl-
ation observed in other human disorders (Li and Yang, 2015).
Materials and methods
Antibodies and reagents
The rabbit polyclonal antibodies to INF2 (used at 1/2,000 for immuno-
fluorescence analysis to detect only exogenous INF2 and at 1/500 for 
immunoblotting) have been described previously (Madrid et al., 2010). 
The sources of commercial antibodies to the indicated proteins were as 
follows: γ-tubulin (rabbit polyclonal; used at 1/1,000 for immunofluo-
rescence analysis; T3559; and mouse mAb IgG1; used at 1/5,000 for 
immunofluorescence analysis; clone GTU-88, T6557), total α-tubulin 
(mouse mAb IgG1; used at 1/2,000 for immunoblotting; clone DM1A; 
T9026), and acetylated tubulin (mouse mAb IgG2b; used at 1/700 or 
1/2,500 for immunofluorescence analysis of tubulin acetylation or hy-
peracetylation, respectively, and 1/2,000 for immunoblotting; clone 
6-11B-1; T7451) were from Sigma-Aldrich; polyglutamylation mod-
ification (mouse mAb IgG1; used at 1/1,000 for immunofluorescence 
analysis and 1/1,000 for immunoblotting; clone GT335; AG-20B-0020) 
was from Adipogen; DIA1 (mouse mAb IgG1; used at 1/100 for im-
munoblotting; clone 51/mDia1; 610848) was from BD Transduction 
Labs; Arl13b (rabbit polyclonal, used at 1/1,000 for immunofluores-
cence analysis, 17711-1-AP) and MRTF-A (rabbit polyclonal; used at 
1/100 for immunofluorescence analysis and 1/1,000 for immunoblot-
ting; 21166-1-AP) were from Proteintech; SRF (rabbit polyclonal; 
used at 1/200 for immunoblotting; G-20, sc-335) was from Santa Cruz 
Biotechnology; Gapdh (mouse mAb IgG1; used at 1/5,000 for immu-
noblotting; clone 6C5, AM4300) was from Ambion. Taxol (paclitaxel), 
nocodazol, and cytochalasin D were from Sigma-Aldrich. SMI FH2 
(1-(3-bromophenyl)-5-(2-furylmethylene)-2-thioxo-hexahydropyrimi-
dine-4,6-dione; 344092) was from Merck. Tubacin and niltubacin were 
from Enzo Life Sciences. The TO-PRO-3 (T3605) and DAPI (268298) 
stains were from Thermo Fisher Scientific and Merck, respectively. 
Fluorescent phalloidin and secondary antibodies conjugated to Alexa 
Fluor 488, 555, 594, or 647 were from Life Technologies. HRP- 
conjugated secondary antibodies were from Jackson ImmunoResearch.
Cell culture conditions
Telomerase-immortalized human pigment epithelial cells RPE-1 (CRL-
4000; ATCC) were grown in DMEM/F12 with 10% FBS, and ECV304 
cells (CRL-1998; ATCC) and Jurkat T cells (TIB-152; ATCC) in 
DMEM with 10% FBS. Cells were incubated at 37°C in an atmosphere 
of 5% CO2/95% air. Primary cilium formation in RPE-1 cells was in-
duced by starving the cells in DMEM/F12 with 0.25% FBS for 24 h.
DNA constructs and transfection conditions
The plasmids expressing shRNAa or shRNAb specific to human 
INF2 used to generate the stable INF2 KD and INF2 KD2 cell clones, 
respectively, were made in the pSR-GFP/neo vector (Oligoengine) 
as described previously (Andrés-Delgado et al., 2010; Madrid et al., 
2010). For DIA1 KD, we expressed shRNA specific to DIA1 cloned 
in the pLKO.1 puro vector (NM_005219.2-2523s1c1; Sigma-Aldrich). 
For CRI SPR/Cas9 INF2 gene editing, the INF2 cDNA sequence was 
analyzed using the Breaking-Cas tool (http ://bioinfogp .cnb .csic .es /
tools /breakingcas), and the target sequence selected (5′-CGG AGA TAC 
GTG CAA CGC CGC GG-3′) was inserted in the pSpCas9(BB)-2A-GFP 
plasmid (plasmid 48138; Addgene; Ran et al., 2013), which was a gift 
from F.  Zhang (Massachusetts Institute of Technology, Cambridge, 
MA). GFP-positive cells were sorted after 48  h of transfection and 
plated. Individual clones were finally screened by immunoblotting 
and immunofluorescence analysis with antibodies to INF2. The DNA 
constructs expressing untagged full-length INF2 proteins with an intact 
or mutated amino acid sequence were cloned in the pCR3.1 DNA 
vector (Invitrogen). The DNA constructs expressing mDia1 and mDia1 
ΔN3 fused to GFP (Ishizaki et al., 2001) were gifts from S. Narumiya 
(Kyoto University, Kyoto, Japan), and that expressing FMNL1-GFP 
(Seth et al., 2006) was donated by M.K. Rosen (University of Texas 
Southwestern Medical Center, Dallas, TX). The plasmids expressing 
wild-type α-TAT1 (plasmid 27099; Addgene) and inactive α-TAT1 
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Δ157N fused to GFP (plasmid 27100; Addgene; Shida et al., 2010) 
were gifts from M.V.  Nachury (Stanford University, Stanford, CA); 
GFP-Smoothened (plasmid 25395; Addgene; Chen et al., 2002), and 
the MRTF-A ΔN100 mutant (plasmid 19848; Addgene; Muehlich 
et al., 2008) were gifts from P.  Beachy (Johns Hopkins University, 
Baltimore, MD) and Ron Prywes (Columbia University, New York, 
NY), respectively; mCherry-ER-3 (plasmid 55041; Addgene) was a gift 
from M. Davidson (The Florida State University, Tallahassee, FL). The 
DNA constructs expressing INF2 deletion proteins (FH1FH2, FH2, and 
IA ΔAlt) as well as those expressing the isolated FH2 domain of mDia1 
and FMNL1 were obtained by PCR and cloned in pCR3.1.  Point 
mutations were introduced using the Quick-Change kit (Stratagene). 
All the constructs were verified by DNA sequencing (Macrogen). Cells 
were transfected with Lipofectamine 2000 (Invitrogen). RPE-1 cell 
clones stably expressing shRNA to INF2 or DIA1 were generated by 
transfection and selection with 0.5 mg/ml G-418 or 1 µg/ml puromycin, 
respectively. The resulting individual clones were trypsinized in situ 
with the help of stainless steel cloning cylinders, and the cells were 
plated onto coverslips and plastic dishes. Finally, the clones were 
screened by immunofluorescence and immunoblot analyses.
Confocal microscopic analysis
Cells were fixed in 4% PFA for 20 min, rinsed, and treated with 10 mM 
glycine for 5 min to quench the aldehyde groups. The cells were per-
meabilized with methanol at –20°C for 5 min, rinsed, and incubated 
with 3% BSA in PBS for 15 min. In the case of Arl13b staining, cells 
were permeabilized with 0.2% Triton X-100. Cells were then incubated 
for 1 h with the appropriate primary antibodies, rinsed several times, 
and incubated for 30 min with the appropriate combination of fluo-
rescent secondary antibodies. Actin filaments were detected with phal-
loidin-Alexa Fluor 647. Coverslips were mounted with Fluoromount 
(Sigma-Aldrich). Controls to assess labeling specificity included in-
cubations with, or omitting, control primary antibodies. Images were 
obtained at room temperature using the following confocal equipment: 
LSM510 coupled to an inverted Axiovert 200 microscope; LSM710 
equipment coupled to an AxioImager.M2 microscope; a multiphoton 
LSM710 coupled to an AxioObserver microscope (Zeiss); 63×/1.4 
oil Plan Apochromat and 100×/1.3 oil Plan Neofluar objectives were 
used. Images were analyzed with Fiji imaging software. Images were 
exported in TIFF format, and their brightness and contrast were opti-
mized with Adobe Photoshop.
Transcription reporter assays
The pGL4.3.4[luc2P]/SRF-RE/Hygro vector (E1350; Promega) con-
tains a sequence of five consensus CArG boxes in tandem separated 
by nucleotide spacers followed by a minimal promoter upstream of 
a modified firefly luciferase gene (5xCArG). This vector was used to 
generate derivatives with the CArG boxes removed (minP construct) 
or replaced by the indicated DNA fragments located upstream of the 
first exon (Prom1 and Prom 2 construct) or at the first intron (Int1 con-
struct) of the human α-TAT1 gene. To generate the plasmid α-TAT1 
CArGs1-4, the sequence containing the five consensus CArG boxes 
of the pGL4.3.4[luc2P]/SRF-RE/Hygro vector was substituted by a 
synthetic sequence containing the CArG 1–4 boxes present in Prom1, 
Prom2, and Int1 but maintaining the nucleotide spacers of the vector. 
The construct α-TAT1 CArGs1-4m was made by mutation of the CArG 
elements in the α-TAT1 CArGs construct in such a way that the four 
central nucleotides of each element were G or C. The DNA constructs 
(150 ng) were transfected in RPE-1 cells together with 50 ng of a Re-
nilla luciferase reporter plasmid, which was used to normalize the re-
sults for the efficiency of the transfection, using Lipofectamine 2000. 
After being starved for 20 h in culture medium with 0.5% FBS, cells 
were incubated with either 20% FBS or 500 nM cytochalasin D and 
were lysed 6 h afterward. Firefly and Renilla luciferase activity, which 
was used as a control of the transfection efficiency, was measured in a 
Sirius tube luminometer (Titertek Berthold) using a Dual-Luciferase 
reporter assay system (E1910; Promega). Each experiment was 
performed in triplicate.
Quantitative RT-PCR
Total RNA from RPE-1 cells was purified using RNeasy (74104; Qia-
gen). mRNA levels were analyzed by quantitative RT-PCR procedures 
using the Super Script III First-Strand Synthesis SuperMix kit (PN 
11752250; Life Technologies) and the qPCR FAST Sybr Green PCR 
Master Mix kit (PN 4367659; Applied Biosystems) in an ABI 7900HT 
apparatus. The results were normalized with respect to the expression of 
Gapdh mRNA in the same samples. As indicated in the corresponding 
figure legend, three to five independent experiments were performed in 
triplicate. Data were analyzed with GenEX software. The oligonucle-
otide primers used for quantitative PCR are listed in Table S1.
Measurement of the G-/F-actin ratio and immunoblot analysis
The G-/F-actin ratio was determined using a commercial G-/F-actin in 
vivo assay kit strictly following the manufacturer’s protocol (BKO37; 
Cytoskeleton). For immunoblotting, samples were subjected to SDS-
PAGE and transferred onto nitrocellulose membranes (Amersham). 
After blocking with 5% nonfat dried milk powder and 0.05% Tween-20 
in PBS, blots were incubated overnight with the appropriate antibodies. 
After several washes, blots were incubated for 30 min with second-
ary antibodies coupled to HRP. The signal was visualized with ECL 
chemiluminescence detection reagent (Thermo Fisher Scientific). Band 
intensities were quantified using ImageJ software, and results were ex-
pressed relative to the control condition.
Statistical analysis
Data are expressed as group means and SEM. t test for independent 
samples was used to establish the statistical significance of differ-
ences between group means.
Online supplemental material
Fig. S1 shows the effect of INF2 KD on the percentage of ciliated cells 
and the size of the cilia, and the effect of a second shRNA to INF2 on 
tubulin acetylation. Fig. S2 shows the effect of INF2 KO on tubulin 
acetylation in various cell lines. Fig. S3 shows representative images of 
the effect of the overexpression of INF2 mutants on tubulin acetylation 
in control RPE-1 cells and an immunoblot analysis of the expression of 
mDia1 and FMNL1 proteins in INF2 KD cells. Fig. S4 shows the effect 
of cytochalasin D on tubulin acetylation in control cells and the effect 
of MRTF-A Δ-N100 expression on tubulin acetylation in SMI FH2-
treated cells. Table S1 shows the sequence of the primers used in the 
quantitative analysis of the expression of the various mRNAs examined.
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